COLUMBUS, Ohio (WSYX) — When a bill designed to cut drug prices for many Ohioans won unanimous approval in the House last year, the bipartisan measure with 60 co-sponsors seemed a good bet to become law.
But House Bill 135 didn’t even get a hearing in the Senate until nearly eight months later. It quietly died in the Senate Health Committee shortly before the two-year legislative session expired at the end of 2022.